Related Experiment Video
Updated: Feb 23, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.4K
Single-Arm Phase II Group Sequential Trial Design with Survival Endpoint at a Fixed Time Point
1Department of Biostatistics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
Statistics in Biopharmaceutical Research
|September 12, 2017
Summary
This study introduces new statistical methods for phase II clinical trials to monitor survival probability. These methods enable flexible trial designs, improving the efficiency of survival probability monitoring.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Survival Analysis
Background:
- Phase II clinical trials are crucial for evaluating drug efficacy.
- Monitoring survival probability is essential in many oncology trials.
- Existing group sequential designs may lack flexibility.
Purpose of the Study:
- To propose novel non-parametric test statistics for single-arm phase II group sequential trials.
- To develop a flexible group sequential design for monitoring survival probability.
- To provide practical tools for clinical trial design.
Main Methods:
- Development of three non-parametric test statistics.
- Simulation studies to evaluate small-sample properties.
- Derivation of sample size formulas for fixed sample tests.
- Application of Brownian motion properties for a sequential conditional probability ratio test.
Main Results:
- The proposed test statistics demonstrate suitable small-sample properties.
- A flexible group sequential design was successfully developed.
- Sample size formulas for fixed sample tests were derived.
- An illustrative example demonstrated the practical application of the proposed method.
Conclusions:
- The proposed non-parametric methods offer a flexible approach for phase II group sequential trial design.
- These methods enhance the monitoring of survival probability in clinical trials.
- The developed procedures provide a valuable addition to clinical trial methodology.
Keywords:
Brownian motionInterim analysisNelson-Aalen estimateSample sizeSingle-arm phase II trialSurvival probabilityMore Related Videos
Related Concept Videos
01:20Actuarial Approach
331
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
331
01:20Comparing the Survival Analysis of Two or More Groups
650
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
650
01:15Assumptions of Survival Analysis
456
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
456
01:18Introduction To Survival Analysis
866
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
866
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
01:24Kaplan-Meier Approach
652
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
652